The effect of frequent hemodialysis on matrix metalloproteinases, their tissue inhibitors, and FGF23: Implications for blood pressure and left ventricular mass modification in the Frequent Hemodialysis Network trials-Reference-Cited by-同舟云学术

The effect of frequent hemodialysis on matrix metalloproteinases, their tissue inhibitors, and FGF23: Implications for blood pressure and left ventricular mass modification in the Frequent Hemodialysis Network trials

Published:2019-12-11 Issue:2 Volume:24 Page:162-174
ISSN:1492-7535
Container-title:Hemodialysis International
language:en
Short-container-title:Hemodialysis International

Author:

Chan Christopher T.¹,Kaysen George A.²,Beck Gerald J.³,Li Minwei³,Lo Joan C.⁴,Rocco Michael V.⁵,Kliger Alan S.⁶,

Affiliation:

1. University Health NetworkToronto General Hospital Toronto Ontario Canada

2. University of California Davis Davis California USA

3. Cleveland Clinic Cleveland Ohio USA

4. Kaiser Permanente Northern California Oakland California USA

5. Wake Forest School of Medicine Winston‐Salem North Carolina USA

6. Yale School of Medicine New Haven Connecticut USA

Funder

Centers for Medicare and Medicaid Services

National Institute of Diabetes and Digestive and Kidney Diseases

Publisher

Wiley

Subject

Nephrology,Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/hdi.12807

Reference18 articles.

1. Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients

2. Phosphate control in end-stage renal disease: barriers and opportunities

3. Fibroblast growth factor 23 and the future of phosphorus management

4. THE CLINICAL EPIDEMIOLOGY OF CARDIOVASCULAR DISEASES IN CHRONIC KIDNEY DISEASE: Clinical Epidemiology of Cardiac Disease in Dialysis Patients: Left Ventricular Hypertrophy, Ischemic Heart Disease, and Cardiac Failure

5. MMP-2 serum concentrations predict mortality in hemodialysis patients: a 5-year cohort study

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of Changes in Vector Length with Changes in Left Ventricular Mass among Patients on Maintenance Hemodialysis;Kidney360;2024-04-24

2. Interventions for fatigue in people with kidney failure requiring dialysis;Cochrane Database of Systematic Reviews;2023-08-31

3. Fibroblast Growth Factor-23-Klotho Axis in Cardiorenal Syndrome: Mediators and Potential Therapeutic Targets;Frontiers in Physiology;2021-11-15

4. The function of matrix metalloproteinase-9 (MMP-9) and its tissue inhibitor (TIMP-1) in several clinical conditions: Results and analysis of our survey;Clinical Hemorheology and Microcirculation;2021-09-23

5. Matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in kidney disease;Advances in Clinical Chemistry;2021